PTGS2 and endothelial dysfunction: Moreover, T2D is associated with endothelial dysfunction, characterized by increased amounts of thromboxane A2 (TXA2) resulting from the overexpression of cyclooxygenase-2 (COX-2) and the inhibition of prostacyclin synthetase.